The United Arab Emirates has officially registered a new crown vaccine for China National Pharmaceutical Group

MEDICINE NETWORK, Dec. 10 (Xinhua) -- The Ministry of Health and Prevention of the United Arab Emirates announced On the 9th that it has officially registered a new crown inactivated vaccine developed by China National Pharmaceutical Group.
The UAE's Ministry of Health and Prevention said in a statement that under the application, the UAE had officially registered a new crown inactivated vaccine developed by China National Pharmaceutical Group, a major vote of confidence in the safety and effectiveness of the vaccine.
phase III clinical trials showed an 86 percent effective rate of the inactivated vaccine against new coronavirus infections, the statement said.
the vaccine has a 99% serum conversion rate of the meso-antibody and 100% effectiveness in preventing the new coronary to moderate and severe conversion of mild disease.
, the analysis showed that the vaccine had no serious safety risks.
Trials (Phase III. Phase III. ) of the China Bio-New Coronary Inactivated Vaccine, a Pharmaceutical Group of China, was launched on June 23 in Abu Dhabi, United Arab Emirates.
July 16th, the Arab side, in cooperation with China National Pharmaceutical Group, began a phase III clinical trial of the new crown vaccine, in which more than 31,000 volunteers from 125 countries and regions lived in the United Arab Emirates participated.
Uae Ministry of Health and Prevention announced on September 14th that the Afghan government had approved the emergency use of the new corona inactivated vaccine developed by China National Pharmaceutical Group for first-line medical workers treating the new crown in the country.
。